688639 华恒生物
交易中 11-10 13:30:50
资讯
新帖
简况
华恒生物（688639）11月9日主力资金净卖出741.54万元
证券之星 · 09:38
华恒生物（688639）11月9日主力资金净卖出741.54万元
华恒生物（688639）11月5日主力资金净卖出201.43万元
证券之星 · 11-06
华恒生物（688639）11月5日主力资金净卖出201.43万元
华恒生物（688639）10月28日主力资金净卖出1068.50万元
证券之星 · 10-29
华恒生物（688639）10月28日主力资金净卖出1068.50万元
股市必读：华恒生物三季报 - 第三季度单季净利润同比下降42.32%
证券之星 · 10-29
股市必读：华恒生物三季报 - 第三季度单季净利润同比下降42.32%
华恒生物(688639)9月30日股东户数1.49万户，较上期增加2.87%
证券之星 · 10-28
华恒生物(688639)9月30日股东户数1.49万户，较上期增加2.87%
华恒生物：2026年第三季度净利润3041.55万元，同比下降42.32%
同花顺 · 10-27
华恒生物：2026年第三季度净利润3041.55万元，同比下降42.32%
华恒生物（688639）10月21日主力资金净卖出686.74万元
证券之星 · 10-22
华恒生物（688639）10月21日主力资金净卖出686.74万元
华恒生物（688639）披露公司2026年限制性股票激励计划首次授予结果公告，10月20日股价上涨0.62%
证券之星 · 10-20
华恒生物（688639）披露公司2026年限制性股票激励计划首次授予结果公告，10月20日股价上涨0.62%
华恒生物：2026年第一次临时股东会决议公告
同花顺 · 10-19
华恒生物：2026年第一次临时股东会决议公告
华恒生物（688639）10月16日主力资金净买入433.24万元
证券之星 · 10-17
华恒生物（688639）10月16日主力资金净买入433.24万元
大健康“A+H”退潮，谁还能上桌？
蓝鲸财经 · 10-15
大健康“A+H”退潮，谁还能上桌？
股市必读：华恒生物新发布《安徽华恒生物科技股份有限公司董事会薪酬与考核委员会关于公司2026年限制性股票激励计划首次授予激励对象名单的公示情况说明及核查意见》
证券之星 · 10-14
股市必读：华恒生物新发布《安徽华恒生物科技股份有限公司董事会薪酬与考核委员会关于公司2026年限制性股票激励计划首次授予激励对象名单的公示情况说明及核查意见》
华恒生物（688639）10月12日主力资金净买入465.34万元
证券之星 · 10-13
华恒生物（688639）10月12日主力资金净买入465.34万元
华恒生物（688639）10月9日主力资金净买入1948.00万元
证券之星 · 10-10
华恒生物（688639）10月9日主力资金净买入1948.00万元
股市必读：华恒生物新发布《安徽华恒生物科技股份有限公司第五届董事会第九次会议决议公告》
证券之星 · 10-08
股市必读：华恒生物新发布《安徽华恒生物科技股份有限公司第五届董事会第九次会议决议公告》
华恒生物：关于召开2026年第一次临时股东会的通知
同花顺 · 09-29
华恒生物：关于召开2026年第一次临时股东会的通知
华恒生物：第五届董事会第九次会议决议公告
同花顺 · 09-29
华恒生物：第五届董事会第九次会议决议公告
华恒生物(688639.SH)拟推2026年限制性股票激励计划
智通财经 · 09-29
华恒生物(688639.SH)拟推2026年限制性股票激励计划
股市必读：华恒生物新发布《安徽华恒生物科技股份有限公司关于召开2026年半年度业绩说明会的公告》
证券之星 · 09-14
股市必读：华恒生物新发布《安徽华恒生物科技股份有限公司关于召开2026年半年度业绩说明会的公告》
每周股票复盘：华恒生物（688639）实控人被刑拘辞职但公司经营正常
证券之星 · 09-13
每周股票复盘：华恒生物（688639）实控人被刑拘辞职但公司经营正常
加载更多
公司概况
公司名称：
安徽华恒生物科技股份有限公司
所属行业：
化学原料和化学制品制造业
上市日期：
2021-04-22
主营业务：
安徽华恒生物科技股份有限公司的主营业务是生物基产品的研发、生产、销售。公司的主要产品是丙氨酸系列、L-缬氨酸、色氨酸、精氨酸、D-泛酸钙、D-泛醇、肌醇、生物基新材料单体、熊果苷。
发行价格：
23.16
{"stockData":{"symbol":"688639","market":"SH","secType":"STK","nameCN":"华恒生物","latestPrice":16.58,"timestamp":1794288650000,"preClose":16.55,"halted":0,"volume":2426584,"delay":0,"changeRate":0.0018,"floatShares":250000000,"shares":250000000,"eps":0.3841,"marketStatus":"交易中","change":0.03,"latestTime":"11-10 13:30:50","open":16.77,"high":16.82,"low":16.37,"amount":40122100,"amplitude":0.0272,"askPrice":16.59,"askSize":65,"bidPrice":16.58,"bidSize":100,"shortable":0,"etf":0,"ttmEps":0.3841,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1794294000000},"marketStatusCode":2,"adr":0,"adjPreClose":16.55,"symbolType":"stock_kcb","openAndCloseTimeList":[[1794274200000,1794281400000],[1794286800000,1794294000000]],"highLimit":18.21,"lowLimit":14.9,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":250115693,"isCdr":false,"pbRate":1.51,"roa":"--","peRate":43.165842,"roe":"4.9%","epsLYR":0.53,"committee":-0.306931,"marketValue":4147000000,"turnoverRate":0.0097,"status":0,"floatMarketCap":4147000000},"requestUrl":"/m/hq/s/688639","defaultTab":"news","newsList":[{"id":"2682356557","title":"华恒生物（688639）11月9日主力资金净卖出741.54万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2682356557","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682356557?lang=zh_cn&edition=full","pubTime":"2026-11-10 09:38","pubTimestamp":1794274707,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年11月9日收盘，华恒生物报收于16.55元，下跌2.07%，换手率1.82%，成交量4.55万手，成交额7631.18万元。近5日资金流向一览见下表：华恒生物融资融券信息显示，融资方面，当日融资买入804.59万元，融资偿还679.71万元，融资净买入124.88万元。华恒生物主营业务：从事生物基产品的研发、生产、销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111000010821.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","688639"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681881944","title":"华恒生物（688639）11月5日主力资金净卖出201.43万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2681881944","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681881944?lang=zh_cn&edition=full","pubTime":"2026-11-06 08:13","pubTimestamp":1793924018,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年11月5日收盘，华恒生物报收于17.53元，上涨9.29%，换手率5.16%，成交量12.89万手，成交额2.19亿元。近5日资金流向一览见下表：华恒生物融资融券信息显示，融资方面，当日融资买入1336.19万元，融资偿还2327.2万元，融资净偿还991.01万元。华恒生物主营业务：从事生物基产品的研发、生产、销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110600008241.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","688639"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679444605","title":"华恒生物（688639）10月28日主力资金净卖出1068.50万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2679444605","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679444605?lang=zh_cn&edition=full","pubTime":"2026-10-29 08:48","pubTimestamp":1793234912,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月28日收盘，华恒生物报收于15.73元，下跌2.66%，换手率2.87%，成交量7.18万手，成交额1.14亿元。近5日资金流向一览见下表：华恒生物融资融券信息显示，融资方面，当日融资买入1494.97万元，融资偿还1575.53万元，融资净偿还80.56万元。华恒生物主营业务：从事生物基产品的研发、生产、销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900015172.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679558419","title":"股市必读：华恒生物三季报 - 第三季度单季净利润同比下降42.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679558419","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679558419?lang=zh_cn&edition=full","pubTime":"2026-10-29 04:07","pubTimestamp":1793218058,"startTime":"0","endTime":"0","summary":"业绩披露要点财务报告2026年前三季度主营收入23.76亿元，同比上升8.32%；归母净利润1.31亿元，同比下降21.68%；扣非净利润1.22亿元，同比下降26.74%。2026年第三季度单季度主营收入7.44亿元，同比上升5.59%；单季度归母净利润3041.55万元，同比下降42.32%；单季度扣非净利润2591.48万元，同比下降50.36%；负债率55.33%，投资收益177.36万元，财务费用5736.0万元，毛利率21.61%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900004210.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678655024","title":"华恒生物(688639)9月30日股东户数1.49万户，较上期增加2.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678655024","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678655024?lang=zh_cn&edition=full","pubTime":"2026-10-28 18:35","pubTimestamp":1793183730,"startTime":"0","endTime":"0","summary":"证券之星消息，近日华恒生物披露，截至2026年9月30日公司股东户数为1.49万户，较6月30日增加416.0户，增幅为2.87%。在化学制品行业个股中，华恒生物股东户数低于行业平均水平，截至9月30日，化学制品行业平均股东户数为3.07万户。从股价来看，2026年6月30日至2026年9月30日，华恒生物区间涨幅为18.4%，在此期间股东户数增加416.0户，增幅为2.87%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800040328.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","688639"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678612768","title":"华恒生物：2026年第三季度净利润3041.55万元，同比下降42.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678612768","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678612768?lang=zh_cn&edition=full","pubTime":"2026-10-27 17:35","pubTimestamp":1793093700,"startTime":"0","endTime":"0","summary":"10月27日，华恒生物(688639.SH)公告，2026年第三季度营业收入7.44亿元，同比增长5.59%；归属于上市公司股东的净利润3041.55万元，同比下降42.32%；扣非净利润2591.48万元，同比下降50.36%。 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261027/c681145380.shtml","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261027/c681145380.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["688639"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677986425","title":"华恒生物（688639）10月21日主力资金净卖出686.74万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677986425","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677986425?lang=zh_cn&edition=full","pubTime":"2026-10-22 08:27","pubTimestamp":1792628855,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月21日收盘，华恒生物报收于17.33元，下跌3.45%，换手率2.2%，成交量5.5万手，成交额9718.21万元。近5日资金流向一览见下表：华恒生物融资融券信息显示，融资方面，当日融资买入1306.11万元，融资偿还993.3万元，融资净买入312.81万元，连续3日净买入累计808.3万元。华恒生物主营业务：从事生物基产品的研发、生产、销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102200006909.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","688639"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676669275","title":"华恒生物（688639）披露公司2026年限制性股票激励计划首次授予结果公告，10月20日股价上涨0.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2676669275","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676669275?lang=zh_cn&edition=full","pubTime":"2026-10-20 17:27","pubTimestamp":1792488446,"startTime":"0","endTime":"0","summary":"截至2026年10月20日收盘，华恒生物报收于17.95元，较前一交易日上涨0.62%，最新总市值为44.9亿元。该股当日开盘17.7元，最高18.1元，最低17.53元，成交额达9860.13万元，换手率为2.21%。公告显示，公司于2026年10月19日确定为2026年限制性股票激励计划的首次授予日，向3名激励对象授予350.00万股第一类限制性股票，向105名激励对象授予601.60万股第二类限制性股票，授予价格为10.69元/股。本次授予已履行相关决策程序，董事会确认授予条件已成就，激励对象均符合资格。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102000026486.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676689275","title":"华恒生物：2026年第一次临时股东会决议公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2676689275","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676689275?lang=zh_cn&edition=full","pubTime":"2026-10-19 21:22","pubTimestamp":1792416120,"startTime":"0","endTime":"0","summary":" 证券日报网讯 10月19日，华恒生物发布公告称，公司于2026年10月19日召开2026年第一次临时股东会，审议通过《关于公司〈2026年限制性股票激励计划(草案)〉及其 ...","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261019/c680851993.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261019/c680851993.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK0229","688639"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676583510","title":"华恒生物（688639）10月16日主力资金净买入433.24万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2676583510","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676583510?lang=zh_cn&edition=full","pubTime":"2026-10-17 08:13","pubTimestamp":1792195990,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月16日收盘，华恒生物报收于18.32元，上涨5.71%，换手率3.67%，成交量9.18万手，成交额1.68亿元。近5日资金流向一览见下表：华恒生物融资融券信息显示，融资方面，当日融资买入1425.19万元，融资偿还1867.99万元，融资净偿还442.8万元。华恒生物主营业务：从事生物基产品的研发、生产、销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101700005569.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","688639"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675619300","title":"大健康“A+H”退潮，谁还能上桌？","url":"https://stock-news.laohu8.com/highlight/detail?id=2675619300","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675619300?lang=zh_cn&edition=full","pubTime":"2026-10-15 17:16","pubTimestamp":1792055774,"startTime":"0","endTime":"0","summary":"2026年以来，A股大健康上市公司的赴港上市明显降温。可以说，港股终止上市也没有与该风波有直接关联。该企业负债率约25%，因此市场猜测“A+H”上市的诉求并非缺钱续命，而是全球化战略布局。头部医疗器械、创新药龙头持续坚守“A+H”双平台战略，持续获得机构认可，港股上市成为全球化发展的配套工具。归根结底，大健康板块的“A+H”上市潮退是行情、规则、企业基本面三重因素叠加的结果。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1792043506360832246","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["LU2213484517.USD","IE0005HP3H50.USD","BK4588","LU0823426480.USD","VXUS","LU1997245177.USD","LU0405327148.USD","LU2488822045.USD","LU0594300419.USD","LU0605514214.HKD","IE0031814852.USD","IE00B29SXG58.USD","LU2424517915.HKD","LU1979443071.USD","IPOS","LU1734074674.USD","BK0251","300760","BK0229","LU1688375341.USD","LU0084288322.USD","LU1064131003.USD","LU2148510915.USD","LU1997245094.SGD","LU0823426308.USD","SGXZ49509284.SGD","KCAI","LU0594300179.USD","LU0359201612.USD","688266","688639","LU1064130708.USD","LU2348773727.SGD","BK4585","LU1820825898.SGD","LU1781817850.SGD","IE00B031J352.USD","LU1146622755.USD","LU1934453819.USD","LU0327786744.USD","IE0008368742.USD","LU2348774022.SGD","LU1655091616.SGD","SGXZ81163826.USD","IE00B031HY20.USD","LU0650527681.SGD","688166","LU0572944931.SGD","LU0359202008.SGD","688506"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675364164","title":"股市必读：华恒生物新发布《安徽华恒生物科技股份有限公司董事会薪酬与考核委员会关于公司2026年限制性股票激励计划首次授予激励对象名单的公示情况说明及核查意见》","url":"https://stock-news.laohu8.com/highlight/detail?id=2675364164","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675364164?lang=zh_cn&edition=full","pubTime":"2026-10-14 03:24","pubTimestamp":1791919459,"startTime":"0","endTime":"0","summary":"公司公告汇总安徽华恒生物科技股份有限公司董事会薪酬与考核委员会关于公司2026年限制性股票激励计划首次授予激励对象名单的公示情况说明及核查意见安徽华恒生物科技股份有限公司于2026年9月29日审议通过《2026年限制性股票激励计划（草案）》及相关议案，并于2026年9月30日至10月9日在公司内部公示首次授予激励对象名单，公示期未收到异议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400003498.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675386236","title":"华恒生物（688639）10月12日主力资金净买入465.34万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675386236","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675386236?lang=zh_cn&edition=full","pubTime":"2026-10-13 08:34","pubTimestamp":1791851653,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月12日收盘，华恒生物报收于18.43元，下跌4.71%，换手率3.47%，成交量8.67万手，成交额1.63亿元。近5日资金流向一览见下表：华恒生物融资融券信息显示，融资方面，当日融资买入1474.98万元，融资偿还1360.13万元，融资净买入114.85万元，连续3日净买入累计1262.73万元。华恒生物主营业务：从事生物基产品的研发、生产、销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300007220.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674860329","title":"华恒生物（688639）10月9日主力资金净买入1948.00万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674860329","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674860329?lang=zh_cn&edition=full","pubTime":"2026-10-10 08:20","pubTimestamp":1791591629,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月9日收盘，华恒生物报收于19.34元，上涨3.09%，换手率3.86%，成交量9.66万手，成交额1.83亿元。近5日资金流向一览见下表：华恒生物融资融券信息显示，融资方面，当日融资买入2491.15万元，融资偿还1402.62万元，融资净买入1088.53万元。华恒生物主营业务：从事生物基产品的研发、生产、销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101000003922.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673012796","title":"股市必读：华恒生物新发布《安徽华恒生物科技股份有限公司第五届董事会第九次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2673012796","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673012796?lang=zh_cn&edition=full","pubTime":"2026-10-08 02:30","pubTimestamp":1791397832,"startTime":"0","endTime":"0","summary":"安徽华恒生物科技股份有限公司2026年限制性股票激励计划实施考核管理办法本办法用于保障2026年限制性股票激励计划顺利实施。安徽华恒生物科技股份有限公司2026年限制性股票激励计划首次授予激励对象名单公司公布2026年限制性股票激励计划首次授予激励对象名单，含第一类和第二类限制性股票。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800001275.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","688639"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671349217","title":"华恒生物：关于召开2026年第一次临时股东会的通知","url":"https://stock-news.laohu8.com/highlight/detail?id=2671349217","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671349217?lang=zh_cn&edition=full","pubTime":"2026-09-29 21:13","pubTimestamp":1790687580,"startTime":"0","endTime":"0","summary":" 证券日报网讯 9月29日，华恒生物发布公告称，公司将于2026年10月19日召开2026年第一次临时股东会。 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260929/c680379312.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260929/c680379312.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671217344","title":"华恒生物：第五届董事会第九次会议决议公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2671217344","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671217344?lang=zh_cn&edition=full","pubTime":"2026-09-29 21:13","pubTimestamp":1790687580,"startTime":"0","endTime":"0","summary":" 证券日报网讯 9月29日，华恒生物发布公告称，公司于2026年9月29日召开第五届董事会第九次会议，审议通过《关于提请股东会授权董事会办理股权激励相关事宜的议 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260929/c680379313.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260929/c680379313.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK0229","688639"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671216739","title":"华恒生物(688639.SH)拟推2026年限制性股票激励计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2671216739","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671216739?lang=zh_cn&edition=full","pubTime":"2026-09-29 19:20","pubTimestamp":1790680856,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华恒生物(688639.SH)发布2026年限制性股票激励计划(草案)，拟向激励对象授予权益总计1,232.37万股，约占激励计划草案公告时公司股本总额的4.93%。其中首次授予1,055.90万股，预留176.47万股。激励计划第一类限制性股票和第二类限制性股票(含预留)的授予价格为10.69元/股。第一类限制性股票激励计划的有效期为自第一类限制性股票授予登记完成之日起至全部第一类限制性股票解除限售或回购注销完毕之日止，最长不超过48个月;第二类限制性股票激励计划的有效期为自第二类限制性股票首次授予之日起至全部第二类限制性股票归属或作废失效之日止，最长不超过48个月。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502224.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667638305","title":"股市必读：华恒生物新发布《安徽华恒生物科技股份有限公司关于召开2026年半年度业绩说明会的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2667638305","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667638305?lang=zh_cn&edition=full","pubTime":"2026-09-14 03:09","pubTimestamp":1789326552,"startTime":"0","endTime":"0","summary":"公司公告汇总：华恒生物将于9月22日召开2026年半年度业绩说明会，董事长樊义等高管将出席。兴业证券股份有限公司关于安徽华恒生物科技股份有限公司2026年半年度持续督导跟踪报告兴业证券作为保荐机构，对华恒生物2026年上半年持续督导情况进行报告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400001245.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667650053","title":"每周股票复盘：华恒生物（688639）实控人被刑拘辞职但公司经营正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2667650053","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667650053?lang=zh_cn&edition=full","pubTime":"2026-09-13 03:09","pubTimestamp":1789240151,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，华恒生物报收于16.62元，较上周的17.7元下跌6.1%。本周，华恒生物9月9日盘中最高价报18.63元。公司公告汇总：华恒生物将于2026年09月22日召开2026年半年度业绩说明会，介绍经营成果及财务状况。兴业证券股份有限公司发布关于安徽华恒生物科技股份有限公司2026年半年度持续督导跟踪报告。实际控制人郭恒华因涉嫌非法吸收公众存款被刑事拘留并辞职，案件与公司经营无关，公司已选举新任董事长及总经理，经营正常。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300000928.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1794288661987,"stockEarnings":[{"period":"1week","weight":0.1026},{"period":"1month","weight":-0.1443},{"period":"3month","weight":-0.0591},{"period":"6month","weight":-0.3657},{"period":"1year","weight":-0.5413},{"period":"ytd","weight":-0.4891}],"compareEarnings":[{"period":"1week","weight":0.0063},{"period":"1month","weight":-0.0401},{"period":"3month","weight":-0.0695},{"period":"6month","weight":-0.1371},{"period":"1year","weight":-0.0842},{"period":"ytd","weight":-0.0776}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"安徽华恒生物科技股份有限公司","boardCode":"AI0026","boardName":"化学原料和化学制品制造业","stockholders":"14901人(较上一季度增加2.87%)","perCapita":"16785股","listingDate":"2021-04-22","address":"安徽省合肥市长丰县双凤工业区","registeredCapital":"25011万元","survey":" 安徽华恒生物科技股份有限公司的主营业务是生物基产品的研发、生产、销售。公司的主要产品是丙氨酸系列、L-缬氨酸、色氨酸、精氨酸、D-泛酸钙、D-泛醇、肌醇、生物基新材料单体、熊果苷。","listedPrice":23.16},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华恒生物(688639)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华恒生物(688639)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华恒生物,688639,华恒生物股票,华恒生物股票老虎,华恒生物股票老虎国际,华恒生物行情,华恒生物股票行情,华恒生物股价,华恒生物股市,华恒生物股票价格,华恒生物股票交易,华恒生物股票购买,华恒生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华恒生物(688639)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华恒生物(688639)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}